What is LOPJLB’s current signal on CDT?

LOPJLB’s latest quantitative signal on CDT Equity Inc. (CDT) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CDT in?

CDT Equity Inc. (CDT) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does CDT Equity Inc. (CDT) do?

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The companyâs pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimotoâs thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for t…

Where is CDT Equity Inc. based / listed?

CDT Equity Inc. is based in US, listed on NASDAQ.

CDT Equity Inc. (CDT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.84-9.68%Close

SELLCRISIS · day 73

[SCORES & PROFILE]

FUND: 15
VALUE: 21
GROWTH: 51
GARP: 8
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC5.6%

REV YoY-

ROE9.3%

EPS YoY-

ROA2.6%

GROSS

NET

[VALUATION]

P/E TTM-0.00

P/E FWD-

SECTOR PE20.33

INDUSTRY PE14.17

P/B0.00

P/FCF-

EV/EBITDA3.99

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E95.28

ALTMAN Z-

CURR RATIO2.14

ND/EBITDA-

BETA1.56

CDT Equity Inc. (CDT)

Key stats

Prediction markets

FUNDAMENTALS

Company news